Differential brain opioid receptor availability in central and peripheral neuropathic pain

Abstract This study used positron emission tomography (PET) and [11C]diprenorphine to compare the in vivo distribution abnormalities of brain opioid receptors (OR) in patients with peripheral (n = 7) and central post‐stroke pain (CPSP, n = 8), matched for intensity and duration. Compared with age‐ and sex‐matched controls, peripheral neuropathic pain (NP) patients showed bilateral and symmetrical OR binding decrease, while in CPSP binding decrease predominated in the hemisphere contralateral to pain. In CPSP patients, interhemispheric comparison demonstrated a significant decrease in opioid binding in posterior midbrain, medial thalamus and the insular, temporal and prefrontal cortices contralateral to the painful side. Peripheral NP patients did not show any lateralised decrease in opioid binding. Direct comparison between the central and peripheral groups confirmed a significant OR decrease in CPSP, contralateral to pain. While bilateral binding decrease in both NP groups may reflect endogenous opioid release secondary to chronic pain, the more important and lateralised decrease specific to CPSP suggests opioid receptor loss or inactivation in receptor‐bearing neurons. Opioid binding decrease was much more extensive than brain anatomical lesions, and was not co‐localised with them; metabolic depression (diaschisis) and/or degeneration of OR neurons‐bearing secondary to central lesions appears therefore as a likely mechanism. Central and peripheral forms of NP may differ in distribution of brain opioid system changes and this in turn might underlie their different sensitivity to opiates.

[1]  K. Berkley,et al.  Diencephalic mechanisms of pain sensation , 1985, Brain Research Reviews.

[2]  C Peter N Watson,et al.  Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. , 1998, Neurology.

[3]  Rickham Pp.  Human Experimentation: Code of Ethics of the World Medical Association (Declaration of Helsinki). , 1964, Canadian Medical Association journal.

[4]  M. Rowbotham,et al.  Oral opioid therapy for chronic peripheral and central neuropathic pain. , 2003, The New England journal of medicine.

[5]  R. Dubner,et al.  Enhancement of dynorphin gene expression in spinal cord following experimental inflammation: stimulus specificity, behavioral parameters and opioid receptor binding , 1988, Pain.

[6]  A. Herz,et al.  A model of chronic pain in the rat: response of multiple opioid systems to adjuvant-induced arthritis , 1986, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[7]  H. Fields.  State-dependent opioid control of pain , 2004, Nature Reviews Neuroscience.

[8]  S. Maeda,et al.  A Possible involvement of the central endorphin system in the autoanalgesia induced by chronic administration of freund's adjuvant solution in rats , 1983, Pain.

[9]  R. Dannals,et al.  Pain activation of human supraspinal opioid pathways as demonstrated by [11C]-carfentanil and positron emission tomography (PET) , 2002, Pain.

[10]  G Brix,et al.  Performance evaluation of a whole-body PET scanner using the NEMA protocol. National Electrical Manufacturers Association. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  J C Froment,et al.  Allodynia after lateral-medullary (Wallenberg) infarct. A PET study. , 1998, Brain : a journal of neurology.

[12]  P. P. Rickham.  HUMAN EXPERIMENTATION. CODE OF ETHICS OF THE WORLD MEDICAL ASSOCIATION. DECLARATION OF HELSINKI. , 1964, British medical journal.

[13]  F Mauguière,et al.  Thalamocortical diaschisis: positron emission tomography in humans. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[14]  A. Zangen,et al.  Nociceptive stimulus induces release of endogenous β-endorphin in the rat brain , 1998, Neuroscience.

[15]  H. Watabe,et al.  Cerebral decreases in opioid receptor binding in patients with central neuropathic pain measured by [11C]diprenorphine binding and PET , 2004, European journal of pain.

[16]  S. Luthra,et al.  Changes in central opioid receptor binding in relation to inflammation and pain in patients with rheumatoid arthritis. , 1994, British journal of rheumatology.

[17]  D. Jourdan,et al.  Evidence for an Involvement of Supraspinal δ- and Spinal μ-Opioid Receptors in the Antihyperalgesic Effect of Chronically Administered Clomipramine in Mononeuropathic Rats , 2003, Journal of Pharmacology and Experimental Therapeutics.

[18]  Joshua A. Bueller,et al.  Regional Mu Opioid Receptor Regulation of Sensory and Affective Dimensions of Pain , 2001, Science.

[19]  Scott T. Grafton,et al.  Automated image registration: I. General methods and intrasubject, intramodality validation. , 1998, Journal of computer assisted tomography.

[20]  F. Benedetti,et al.  Dose-response relationship of opioids in nociceptive and neuropathic postoperative pain , 1998, Pain.

[21]  A. Lawrence,et al.  Chronic Antidepressant Treatment Causes a Selective Reduction of μ-Opioid Receptor Binding and Functional Coupling to G Proteins in the Amygdala of Fawn-Hooded Rats , 2004, Journal of Pharmacology and Experimental Therapeutics.

[22]  H. N. Wagner,et al.  Multicompartmental Analysis of [11C]-Carfentanil Binding to Opiate Receptors in Humans Measured by Positron Emission Tomography , 1989, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[23]  Robert A Koeppe,et al.  mu-opioid receptor-mediated antinociceptive responses differ in men and women. , 2002, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[24]  Joshua A. Bueller,et al.  μ-Opioid Receptor-Mediated Antinociceptive Responses Differ in Men and Women , 2002, The Journal of Neuroscience.

[25]  M. Rowbotham,et al.  Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia , 1991, Neurology.

[26]  A. Zangen,et al.  Nociceptive stimulus induces release of endogenous beta-endorphin in the rat brain. , 1998, Neuroscience.

[27]  H. Boecker,et al.  What to learn from in vivo opioidergic brain imaging? , 2005, European journal of pain.

[28]  J. Vanneste,et al.  Prolonged treatment with transdermal fentanyl in neuropathic pain. , 1998, Journal of pain and symptom management.

[29]  J. Zubieta,et al.  Gender and age influences on human brain mu-opioid receptor binding measured by PET. , 1999, The American journal of psychiatry.

[30]  J. Vanneste,et al.  Randomised double-blind active-placebo-controlled crossover trial of intravenous fentanyl in neuropathic pain , 1997, The Lancet.

[31]  D. Pfaff,et al.  Transneuronal degeneration in the midbrain central gray following chemical lesions in the ventromedial nucleus: A qualitative and quantitative analysis , 1990, Neuroscience.

[32]  J. Frost,et al.  Detection and quantification of opiate receptors in Man by positron emission tomography. Potential applications to the study of pain , 1990, Neurophysiologie Clinique/Clinical Neurophysiology.

[33]  Sajinder K. Luthra,et al.  Automated radiosyntheses of [6-O-methyl-11C]diprenorphine and [6-O-methyl-11C]buprenorphine from 3-O-trityl protected precursors , 1994 .

[34]  Frode Willoch,et al.  Central poststroke pain and reduced opioid receptor binding within pain processing circuitries: a [11C]diprenorphine PET study , 2004, Pain.

[35]  R. Olson,et al.  Endogenous opiates: 1998☆ , 1999, Peptides.